HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription.

Source:http://linkedlifedata.com/resource/pubmed/id/17209012

Proc. Natl. Acad. Sci. U.S.A. 2007 Jan 16 104 3 1015-20

Download in:

View as

Triples

General Info

PMID
17209012